Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Garry Pairaudeau

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Bioorganic & Medicinal Chemistry Letters|November 15, 2011
From libraries to candidate: the discovery of new ultra long-acting dibasic β₂-adrenoceptor agonistsLilian Alcaraz, Andrew Bailey, Elaine Cadogan, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of AZD3199, An Inhaled Ultralong Acting β2 Receptor Agonist with Rapid Onset of ActionMichael J Stocks, Lilian Alcaraz, Andrew Bailey, et al.
Bioorganic & Medicinal Chemistry Letters|June 10, 2011
Design driven HtL: The discovery and synthesis of new high efficacy β₂-agonistsMichael J Stocks, Lilian Alcaraz, Andrew Bailey, et al.
RSC Medicinal Chemistry|May 27, 2021
Collaborative virtual screening to elaborate an imidazo[1,2-<i>a</i>]pyridine hit series for visceral leishmaniasisYuichiro Akao, Stacie Canan, Yafeng Cao, et al.
ACS Pharmacology & Translational Science|April 17, 2020
Identification of Small-Molecule Positive Modulators of Calcitonin-like Receptor-Based ReceptorsErica R Hendrikse, Lydia P Liew, Rebekah L Bower, et al.
Journal of Medicinal Chemistry|January 6, 2023
Collaborative Virtual Screening Identifies a 2-Aryl-4-aminoquinazoline Series with Efficacy in an <i>In Vivo</i> Model of <i>Trypanosoma cruzi</i> InfectionTaisuke Tawaraishi, Atsuko Ochida, Yuichiro Akao, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2007
From ATP to AZD6140: the discovery of an orally active reversible P2Y12 receptor antagonist for the prevention of thrombosisBrian Springthorpe, Andrew Bailey, Patrick Barton, et al.
Nature Reviews. Drug Discovery|December 15, 2021
IMI European Lead Factory - democratizing access to high-throughput screeningPhilip S Jones, Sylviane Boucharens, Stuart P McElroy, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Bioorganic & Medicinal Chemistry Letters|November 15, 2011
From libraries to candidate: the discovery of new ultra long-acting dibasic β₂-adrenoceptor agonistsLilian Alcaraz, Andrew Bailey, Elaine Cadogan, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of AZD3199, An Inhaled Ultralong Acting β2 Receptor Agonist with Rapid Onset of ActionMichael J Stocks, Lilian Alcaraz, Andrew Bailey, et al.
Bioorganic & Medicinal Chemistry Letters|June 10, 2011
Design driven HtL: The discovery and synthesis of new high efficacy β₂-agonistsMichael J Stocks, Lilian Alcaraz, Andrew Bailey, et al.
RSC Medicinal Chemistry|May 27, 2021
Collaborative virtual screening to elaborate an imidazo[1,2-<i>a</i>]pyridine hit series for visceral leishmaniasisYuichiro Akao, Stacie Canan, Yafeng Cao, et al.
ACS Pharmacology & Translational Science|April 17, 2020
Identification of Small-Molecule Positive Modulators of Calcitonin-like Receptor-Based ReceptorsErica R Hendrikse, Lydia P Liew, Rebekah L Bower, et al.
Journal of Medicinal Chemistry|January 6, 2023
Collaborative Virtual Screening Identifies a 2-Aryl-4-aminoquinazoline Series with Efficacy in an <i>In Vivo</i> Model of <i>Trypanosoma cruzi</i> InfectionTaisuke Tawaraishi, Atsuko Ochida, Yuichiro Akao, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2007
From ATP to AZD6140: the discovery of an orally active reversible P2Y12 receptor antagonist for the prevention of thrombosisBrian Springthorpe, Andrew Bailey, Patrick Barton, et al.
Nature Reviews. Drug Discovery|December 15, 2021
IMI European Lead Factory - democratizing access to high-throughput screeningPhilip S Jones, Sylviane Boucharens, Stuart P McElroy, et al.
Pageof 3